Pneumococcal vaccination prevented severe LRTIs in adults: a causal inference framework applied in registry data

J Clin Epidemiol. 2022 Mar:143:118-127. doi: 10.1016/j.jclinepi.2021.12.008. Epub 2021 Dec 8.

Abstract

Objectives: We estimated the effect of pneumococcal vaccination (PV) on acute lower respiratory tract infections (LRTIs) in various age and risk groups using different methods within a causal inference methodological framework.

Study design and setting: We used data from a general practitioners' morbidity registry for the year 2019. Both traditional statistical methods (regression-based and propensity score methods) and machine learning techniques were deployed. Multiple imputation was used to account for missing data. Relative risks (RRs) with 95% confidence intervals were estimated. Sensitivity analyses were performed to account for the severity of LRTIs and differences in vaccination registration.

Results: All methods showed a standardized mean difference below 0.1 for each covariate. No method was found to be superior to another. PV (combination of conjugate and polysaccharide vaccine) had an overall protective effect for severe LRTIs. PV was protective in different age and risk groups, especially in people aged 50-84 years with an intermediate risk group.

Conclusion: Using several techniques, PV was found to prevent severe LRTIs and confirmed the recommendations of the Belgian Superior Health Council.

Keywords: Causal inference; Machine learning; Pneumococcal vaccine; Propensity score; Registry data; Relative risk.

MeSH terms

  • Adult
  • Humans
  • Pneumococcal Infections* / prevention & control
  • Pneumococcal Vaccines / therapeutic use
  • Propensity Score
  • Registries
  • Respiratory Tract Infections*
  • Risk Factors
  • Vaccination

Substances

  • Pneumococcal Vaccines